Home › Cholesterol › Tennessee
Cholesterol clinical trials in Tennessee
4 studies for Cholesterol are looking for participants at sites in Tennessee.
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Rosuvastatin on LDL-C in Patients With Hypercholesterolaemia
- Research Site, Bristol
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Oct 5, 2026 · NCT07619118Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Stern Cardiovascular Center, Germantown
- Ballad Health System, Greeneville
- Apex Research Foundation, LLC, Jackson
- and 2 more
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT06909565A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
- Research Site, Knoxville
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Sep 10, 2026 · NCT07619131Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
- University of Tennessee Medical Center, Knoxville
- University of Tennessee Health Science Center/Regional One Health, Memphis
Recruiting
Ages 18 and older · All sexes · Updated Jan 29, 2026 · NCT06374277From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.